Related references
Note: Only part of the references are listed.Paraoxonase 1-treated oxLDL promotes cholesterol efflux from macrophages by stimulating the PPARγ-LXRα-ABCA1 pathway
Souade Ikhlef et al.
FEBS LETTERS (2016)
HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events
Anand Rohatgi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Extra-virgin olive oil consumption improves the capacity of HDL to mediate cholesterol efflux and increases ABCA1 and ABCG1 expression in human macrophages
Olfa Helal et al.
BRITISH JOURNAL OF NUTRITION (2013)
Quantitative Assessment of the Influence of Paraoxonase 1 Activity and Coronary Heart Disease Risk
Mingsong Wang et al.
DNA AND CELL BIOLOGY (2012)
Purified human paraoxonase-1 interacts with plasma membrane lipid rafts and mediates cholesterol efflux from macrophages
Hicham Berrougui et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Health benefits of high-density lipoproteins in preventing cardiovascular diseases
Hicham Berrougui et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2012)
Association between PON1 activity and coronary heart disease risk: A meta-analysis based on 43 studies
Yuan Zhao et al.
MOLECULAR GENETICS AND METABOLISM (2012)
The anti-inflammatory effect of paraoxonase 1 against oxidized lipids depends on its association with high density lipoproteins
Soumaya Loued et al.
LIFE SCIENCES (2012)
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
Amit V. Khera et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Structures of Discoidal High Density Lipoproteins A COMBINED COMPUTATIONAL-EXPERIMENTAL APPROACH
Feifei Gu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
TNF-α decreases ABCA1 expression and attenuates HDL cholesterol efflux in the human intestinal cell line Caco-2
F. Jeffrey Field et al.
JOURNAL OF LIPID RESEARCH (2010)
The end of the road for CETP inhibitors after torcetrapib?
Tisha Joy et al.
CURRENT OPINION IN CARDIOLOGY (2009)
Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk
Tamali Bhattacharyya et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Enhancing apolipoprotein A-I-dependent cholesterol efflux elevates cholesterol export from macrophages in vivo
Nigora Mukhamedova et al.
JOURNAL OF LIPID RESEARCH (2008)
Effects of torcetrapib in patients at high risk for coronary events
Philip J. Barter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Molecular regulation of macrophage reverse cholesterol transport
Xun Wang et al.
CURRENT OPINION IN CARDIOLOGY (2007)
Lysophosphatidylcholine promotes cholesterol efflux from mouse macrophage foam cells via PPAR gamma-LXR alpha-ABCA1-dependent pathway associated with apoE
Mengjun Hou et al.
CELL BIOCHEMISTRY AND FUNCTION (2007)
Macrophage ATP-binding cassette transporter A1 overexpression inhibits atherosclerotic lesion progression in low-density lipoprotein receptor knockout mice
M Van Eck et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
The catalytic histidine dyad of high density lipoprotein-associated serum paraoxonase-1 (PON1) is essential for PON1-mediated inhibition of low density lipoprotein oxidation and stimulation of macrophage cholesterol efflux
M Rosenblat et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Oxidized LDL downregulates ATP-binding cassette transporter-1 in human vascular endothelial cells via inhibiting liver X receptor (LXR)
Y Zhu et al.
CARDIOVASCULAR RESEARCH (2005)
Anthocyanins induce cholesterol efflux from mouse peritoneal macrophages -: The role of the peroxisome proliferator-activated receptor γ-liver X receptor α-ABCA1 pathway
M Xia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Atherosclerosis in aged mice over-expressing the reverse cholesterol transport genes
JA Berti et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2005)
Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine
M Rosenblat et al.
ATHEROSCLEROSIS (2005)
ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation
MA Kennedy et al.
CELL METABOLISM (2005)
Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes
M Harel et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2004)
Study of factors influencing the decreased HDL associated PON1 activity with aging
I Seres et al.
EXPERIMENTAL GERONTOLOGY (2004)
ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins
N Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
ABCAl-mediated cholesterol efflux is defective in free cholesterol-loaded macrophages
B Feng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice
A Tward et al.
CIRCULATION (2002)
Helical apolipoproteins stabilize ATP-binding cassette transporter A1 by protecting it from thiol protease-mediated degradation
R Arakawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Synthetic LXR ligand inhibits the development of atherosclerosis in mice
SB Joseph et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
ABCA1 mRNA and protein distribution patterns predict multiple different roles and levels of regulation
CL Wellington et al.
LABORATORY INVESTIGATION (2002)
Protein oxidation and ageing
S Linton et al.
EXPERIMENTAL GERONTOLOGY (2001)
Apolipoprotein specificity for lipid efflux by the human ABCAI transporter
AT Remaley et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis
A Chawla et al.
MOLECULAR CELL (2001)
Share Paper
